151 related articles for article (PubMed ID: 21147548)
1. Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa.
Paluszczak J; Misiak P; Wierzbicka M; Woźniak A; Baer-Dubowska W
Oral Oncol; 2011 Feb; 47(2):104-7. PubMed ID: 21147548
[TBL] [Abstract][Full Text] [Related]
2. Frequent gene hypermethylation in laryngeal cancer cell lines and the resistance to demethylation induction by plant polyphenols.
Paluszczak J; Krajka-Kuźniak V; Małecka Z; Jarmuż M; Kostrzewska-Poczekaj M; Grenman R; Baer-Dubowska W
Toxicol In Vitro; 2011 Feb; 25(1):213-21. PubMed ID: 21078381
[TBL] [Abstract][Full Text] [Related]
3. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer].
Zhang S; Kong WJ
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):469-71. PubMed ID: 15555335
[TBL] [Abstract][Full Text] [Related]
4. Frequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomas.
Yanagawa N; Osakabe M; Hayashi M; Tamura G; Motoyama T
Virchows Arch; 2008 Apr; 452(4):377-82. PubMed ID: 18299890
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas.
Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
Oral Oncol; 2011 Aug; 47(8):702-8. PubMed ID: 21697000
[TBL] [Abstract][Full Text] [Related]
6. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
7. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
[TBL] [Abstract][Full Text] [Related]
8. Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men.
Yanagawa N; Osakabe M; Hayashi M; Tamura G; Motoyama T
Pathol Int; 2008 Aug; 58(8):477-82. PubMed ID: 18705766
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
Kim H; Kwon YM; Kim JS; Lee H; Park JH; Shim YM; Han J; Park J; Kim DH
J Clin Oncol; 2004 Jun; 22(12):2363-70. PubMed ID: 15197197
[TBL] [Abstract][Full Text] [Related]
10. [Methylation of promoter and expression of FHIT gene in laryngeal squamous cell carcinoma].
Yin D; Dong M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Mar; 19(6):253-5, 258. PubMed ID: 16013507
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
Schildhaus HU; Kröckel I; Lippert H; Malfertheiner P; Roessner A; Schneider-Stock R
Int J Oncol; 2005 Jun; 26(6):1493-500. PubMed ID: 15870861
[TBL] [Abstract][Full Text] [Related]
12. Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues.
Kulkarni V; Saranath D
Oral Oncol; 2004 Feb; 40(2):145-53. PubMed ID: 14693237
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R
Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients.
Chan MW; Chan LW; Tang NL; Tong JH; Lo KW; Lee TL; Cheung HY; Wong WS; Chan PS; Lai FM; To KF
Clin Cancer Res; 2002 Feb; 8(2):464-70. PubMed ID: 11839665
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma.
Fischer JR; Ohnmacht U; Rieger N; Zemaitis M; Stoffregen C; Kostrzewa M; Buchholz E; Manegold C; Lahm H
Lung Cancer; 2006 Oct; 54(1):109-16. PubMed ID: 16893590
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
[TBL] [Abstract][Full Text] [Related]
18. CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer.
Gutiérrez MI; Siraj AK; Khaled H; Koon N; El-Rifai W; Bhatia K
Mod Pathol; 2004 Oct; 17(10):1268-74. PubMed ID: 15154012
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.
Chang Q; Pang JC; Li KK; Poon WS; Zhou L; Ng HK
Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119
[TBL] [Abstract][Full Text] [Related]
20. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.
Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W
J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
